II

ARTHEx Biotech Announces Presentations at the 19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) and Tides Europe 2023

Retrieved on: 
Tuesday, October 24, 2023
Poster, Oligonucleotide, OTS, MicroRNA, NL, II, Pharmaceutical industry

VALENCIA, Spain, Oct. 24, 2023 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, announced today the presentation of posters and oral talks at the 19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS), taking place October 22-25, 2023, in Barcelona, Spain, and Tides Europe 2023, taking place October 30-November 1, 2023, in Amsterdam, NL.

Key Points: 
  • VALENCIA, Spain, Oct. 24, 2023 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, announced today the presentation of posters and oral talks at the 19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS), taking place October 22-25, 2023, in Barcelona, Spain, and Tides Europe 2023, taking place October 30-November 1, 2023, in Amsterdam, NL.
  • Details of the ARTHEx presentations during OTS are below:
    ARTHEx's posters will be available for viewing during the Poster Sessions I and II, being held on October 24 and October 25, 2023.
  • Titles are listed below:
    "Comprehensive assessment of potential hybridization-dependent off-target effects of ATX-01 including In Silico, In Vitro and In Vivo evaluation."
  • Details of the ARTHEx presentation during Tides Europe is below:
    More information about the Tides Europe meeting can be found here: link .

Andesa Successfully Completes SOC 1®, SOC 2®, and SOC 3® Examinations

Retrieved on: 
Tuesday, October 24, 2023
SOC, Policy, American Institute, AICPA, II, Security, Type 2, American Institute of Certified Public Accountants, Certified Public Accountant, General counsel, System, Financial adviser, Video game, Audit, Synempora andesae

ALLENTOWN, Pa., Oct. 24, 2023 /PRNewswire-PRWeb/ -- Andesa, a leading policy lifecycle solutions provider for the life insurance and annuities industry, announced today the successful completion of its annual Service Organization Control (SOC) examinations. The SOC examinations were conducted according to attestation standards created and managed by the American Institute of Certified Public Accountants (AICPA). The AICPA has established three, distinct SOC examination engagements – SOC 1®, SOC 2®, and SOC 3®.

Key Points: 
  • The SOC examinations were conducted according to attestation standards created and managed by the American Institute of Certified Public Accountants (AICPA).
  • The AICPA has established three, distinct SOC examination engagements – SOC 1®, SOC 2®, and SOC 3®.
  • "We are pleased to announce the successful completion of the SOC 1® Type II and SOC 2® Type II audits.
  • "We are pleased to announce the successful completion of the SOC 1® Type II and SOC 2® Type II audits.

X-ray Inspection System Market worth $1.1 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, October 24, 2023
Nondestructive testing, NDT, Digital radiography, Element, SMT, Omron, Microscope, Mettler Toledo, 2D, II, Visual Test, Dye, Equipment, Current source, Maintenance (technical), Segment, Growth, Placement, Comet Group, Science and technology in Asia, Economic development, AOI, Electronics, Petrochemical, Component, Nikon, Radiography, Automotive industry, Investment, Electricity generation, Nordson Corporation, Quality control, Inspection, Video game, Printed circuit board, Medical imaging, Application, Geography, Ultrasound

The 2D segment in X-ray inspection systems are expected to dominate owing to versatility and the X-ray inspection system is well-suited for numerous applications in diverse industries, including electronics, automotive, aerospace, and food production.

Key Points: 
  • The 2D segment in X-ray inspection systems are expected to dominate owing to versatility and the X-ray inspection system is well-suited for numerous applications in diverse industries, including electronics, automotive, aerospace, and food production.
  • North America to dominate X-ray inspection system market during the forecast period.
  • North America is expected to dominate in the X-ray inspection system market during the forecast period.
  • Furthermore, the increasing adoption of X-ray inspection systems in manufacturing and quality control procedures is a significant driver of this growth.

United States Clinical Trials Support Services Markets, 2023-2028 with Charles River Laboratories, IQVIA, Icon, Labcorp Drug Development, and Syneos Health Dominating - ResearchAndMarkets.com

Retrieved on: 
Friday, October 20, 2023
Health, Clinical Trials, Incidence, III, Syneos Health, Charles River Laboratories, ICON PLC, II, Prevalence, Conditional sentence, Research, Phase, Growth, Clinical trial, Labcorp Drug Development, Cancer, Patient, Pharmaceutical industry

The "US Clinical Trials Support Services Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US Clinical Trials Support Services Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The demand for clinical trial support services is witnessing a significant upswing, driven by various factors such as a surge in research and development activities, a high prevalence of chronic diseases, and the increasing adoption of clinical trial support services.
  • Prominent companies dominating the US clinical trial support services market include Charles River Laboratories, IQVIA Inc, Icon plc, Labcorp Drug Development, and Syneos Health.
  • The report offers an in-depth analysis of the current market dynamics for the US clinical trial support services market from 2023 to 2028.

New Study Using Biological Dynamics’ ExoVerita Platform Validates Exosome Detection of Early-Stage Pancreatic Ductal Adenocarcinoma (PDAC)

Retrieved on: 
Thursday, October 19, 2023
Managed Care, Research, Other Health, Oncology, Medical Devices, Infectious Diseases, Genetics, Surgery, Clinical Trials, Science, Biotechnology, Health, Other Science, Neoplasm, Survival, Biomarker, II, Oregon Health & Science University, Exosome, Detection, Cell, Nanoparticle, Biological Dynamics of Forest Fragments Project, Disease, Cancer, OHSU, Machine learning, Survival rate, Pancreatic cancer, PDAC, Pharmaceutical industry, Medical imaging, Verita

Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in Nature’s Communications Medicine titled “ Development of a Blood-Based EV Classifier for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma .” The research demonstrates the effectiveness of exosome-isolation technology in detecting Stage I and II pancreatic ductal adenocarcinoma (PDAC), using an independent validation cohort.

Key Points: 
  • Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in Nature’s Communications Medicine titled “ Development of a Blood-Based EV Classifier for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma .” The research demonstrates the effectiveness of exosome-isolation technology in detecting Stage I and II pancreatic ductal adenocarcinoma (PDAC), using an independent validation cohort.
  • Biological Dynamics’ ExoVita Pancreas assay, powered by the ExoVerita™ platform, uses the AC Electrokinetics method for exosome isolation.
  • “Driven by our Verita technology, the ExoVita test can detect challenging diseases like pancreatic cancer earlier than ever.
  • With further testing in real-world settings, we are confident our exosome enabled test will be useful for high-risk surveillance and early detection of pancreatic cancer, resulting in improved patient outcomes.”

Medical Device Testing Market worth $13.5 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, October 23, 2023
Neurostimulation, GSM, Intertek, CDMA, II, Consumer, Construction, Medical device, Region, Equipment, UMTS, Organization, SGS, LTE, Row, Growth, Final good, Bureau Veritas, Hardware, TIC, Confidentiality, Culture, Safety, Testing, inspection and certification, Bluetooth, Mobile phone, Food, Certification, Medicine, Geography, Inspection, Automotive industry, Mining, Telecommunications

The certification services segment in the medical device testing market is projected to exhibit the highest compound annual growth rate (CAGR) due to several factors.

Key Points: 
  • The certification services segment in the medical device testing market is projected to exhibit the highest compound annual growth rate (CAGR) due to several factors.
  • Medical device testing market for in-house segment to hold the highest market share during the forecast period.
  • Medical device testing market for active implant medical devices to exhibit the highest CAGR during the forecast period.
  • These players have a strong market presence for medical device testing across various countries in North America, Europe, Asia Pacific, and RoW.

Human Augmentation Market worth $545.1 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, October 20, 2023
Apple Inc., Science, Fashion, Aerospace, Full body scanner, Ageing, Accelerometer, Sport, Ascending limb of loop of Henle, II, Biotechnology, Region, Workforce, Research, Augment, Human, Cognition Network Technology, Public utility, Artificial intelligence, Row, Enterprise, Growth, Hardware, Fossil fuel, Power, Component, Navigation, Investment, Defense, Robotics, Consumer electronics, Samsung, Software, Video game, Microsoft, Gyroscope, Application, Geography, Vertical

These factors collectively contribute to the expansion of exoskeletons in the human augmentation landscape.

Key Points: 
  • These factors collectively contribute to the expansion of exoskeletons in the human augmentation landscape.
  • Human Augmentation market for commercial end-users holds the highest CAGR during the forecast period.
  • Human Augmentation market for Asia Pacific to hold the highest CAGR during the forecast period.
  • These players have a strong market presence for human augmentation across various countries in North America, Europe, Asia Pacific, and RoW.

Human Augmentation Market worth $545.1 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, October 20, 2023
Apple Inc., Science, Fashion, Aerospace, Full body scanner, Ageing, Accelerometer, Sport, Ascending limb of loop of Henle, II, Biotechnology, Region, Workforce, Research, Augment, Human, Cognition Network Technology, Public utility, Artificial intelligence, Row, Enterprise, Growth, Hardware, Fossil fuel, Power, Component, Navigation, Investment, Defense, Robotics, Consumer electronics, Samsung, Software, Video game, Microsoft, Gyroscope, Application, Geography, Vertical

These factors collectively contribute to the expansion of exoskeletons in the human augmentation landscape.

Key Points: 
  • These factors collectively contribute to the expansion of exoskeletons in the human augmentation landscape.
  • Human Augmentation market for commercial end-users holds the highest CAGR during the forecast period.
  • Human Augmentation market for Asia Pacific to hold the highest CAGR during the forecast period.
  • These players have a strong market presence for human augmentation across various countries in North America, Europe, Asia Pacific, and RoW.

Freedom House Welcomes New Board Co-Chair Wendell L. Willkie, II

Retrieved on: 
Thursday, October 19, 2023
Fascism, United States Secretary of Education, Democracy, Freedom, GOP, II, Government, Wendell, Congress, Commerce, U.S. Department of Commerce Office of Security, Research, Nazi Germany, Multimedia, Freedom House, Private sector, Ronald Reagan, Willkie, Democrat, U.S. Department of Defense Strategy for Operating in Cyberspace, American Enterprise Institute, Airline, Management, Trustee, New York University

WASHINGTON, Oct. 19, 2023 /PRNewswire/ -- Freedom House is pleased to announce that Wendell L. Willkie, II will join former Congresswoman Jane Harman as co-chair of the Freedom House Board of Trustees.

Key Points: 
  • WASHINGTON, Oct. 19, 2023 /PRNewswire/ -- Freedom House is pleased to announce that Wendell L. Willkie, II will join former Congresswoman Jane Harman as co-chair of the Freedom House Board of Trustees.
  • "Wendell's exceptional experience in senior posts in government, the private sector, and academia make him a perfect partner to lead Freedom House during these tumultuous times.
  • "I could not be more pleased that Wendell is rejoining the board in such an important leadership position," said Michael J. Abramowitz, president of Freedom House.
  • He served on the Freedom House Board between 1993 and 2005, and more recently as an emeritus trustee.

Night Vision Device Market worth $11.2 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, October 19, 2023
RTX, Video content analysis, NVD, Monitor, II, Building inspection, Region, IR, BAE Systems, Teledyne Technologies, Aviation, Law enforcement, Storage device, Night vision, MAK Technologies, Inc., Hunting, Safety, VMS, Overalls, Investment, IP, Mobile device, Telescopic sight, Analog, Modularity

Portable night vision devices are experiencing increasing demand due to a range of driving factors.

Key Points: 
  • Portable night vision devices are experiencing increasing demand due to a range of driving factors.
  • The increasing population and need for security and surveillance in these countries are projected to drive the night vision devices market during the forecast period.
  • The night vision devices market in Asia Pacific is expected to record the highest CAGR during the forecast period.
  • China, Japan, and India are among the major countries driving the night vision devices market in the region.